Login

Join Now

The voice of utah’s life sciences community

BioUtah is the common voice and flag bearer for Utah’s life sciences industry comprised of medical devices, pharmaceutical, diagnostics, and biotechnology. Together we form an ecosystem that fosters collaboration, promotes innovation and delivers technology that saves lives.

Learn More

Medical Device

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

March 16-17, 2023

early registration now open

Utah Life Sciences by the Numbers

Job Growth

Utah's life sciences industry had the second highest industry annual job growth in the nation from 2019-2020.

Source: Pace, L. and Burton, L., Growth Trends in Utah's Life Sciences Industry, Kem C. Gardner Policy Institute, Univesity of Utah, 2021

Economic Impact

Utah's medical device industry ranks in the top 10 in the nation in three different economic impact metrics, including industry revenues (#8), payroll (#9), and employment (#9).

Source: The Economic Impact o the Medical Technology Industry: A 2021 satistical update on the contributions of the industry ot national and state economic conditions, Advamed, 2021

BioUtah News

February 3, 2023
BioUtah News
Sumitomo Pharma Oncology Presented Preliminary Data From Phase 1/2 Clinical Study Evaluating Investigational Agent TP-3654 in Patients With Myelofibrosis at American Society of Hematology 2022 Annual Meeting & Exposition

Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, presented new data from the ongoing Phase 1/2 study evaluating TP-3654, an investigational selective oral PIM1 kinase inhibitor, in patients with myelofibrosis (MF) previously treated with or ineligible for JAK inhibitor therapy at the 64th American Society of Hematology (ASH) Annual Meeting & […]

February 2, 2023
BioUtah News
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in Multiple Sclerosis by Sanofi

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for the treatment of neurodegenerative diseases and lysosomal storage diseases, today announced that its partner Sanofi has commenced dosing in a Phase 2 study […]

February 2, 2023
BioUtah News
Quansys Biosciences launches new NHP line of Multiplex ELISA Assays

NHP-specific ELISAs now available from Quansys Biosciences

January 30, 2023
BioUtah News
UTAH’S LIFE SCIENCES INDUSTRY TAKES TO THE HILL

Utah’s vibrant life sciences industry was on full display January 27 as part of the Governor’s Office of Economic Opportunity “Life Sciences Day on the Hill”. The event, held at the state capitol, provided lawmakers the opportunity to interact one-on-one with leaders from local med tech, biotech and diagnostics companies. More than two dozen companies […]

January 26, 2023
BioUtah News
BIOMERICS COMPLETES CONNECTICUT EXPANSION

SALT LAKE CITY, Jan. 20, 2023 /PRNewswire/ — Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced completion of a 26,000 sq. ft. expansion of its Monroe, CTfacility.  The Monroe facility is the headquarters of Biomerics’ micro-metals processing business and specializes in the design, development, and manufacture of complex […]

January 26, 2023
BioUtah News
Intermountain Healthcare is now “Intermountain Health”

Intermountain Healthcare has now officially changed its name to Intermountain Health, reflecting an added emphasis on keeping people healthy, as well as continuing to provide world-class medical care at its hospitals and clinics. Intermountain Health announced the name change in 2022 and that the name would be officially changed in 2023. The name change was […]

January 26, 2023
BioUtah News
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

January 26, 2023
BioUtah News
POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE

POSITIVE TWO-YEAR CLINICAL DATA ANNOUNCED FOR STUDY OF DISCOGENIC PROGENITOR CELL THERAPY (IDCT) FOR DEGENERATIVE DISC DISEASE

From Here to There

See how BioUtah, the only trade association dedicated solely to Utah’s Life Sciences industry, can help your business grow.


Networking

Advocacy

Investment

Workforce Development

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors